Risk of Stent Stenosis after Implanting a First-Generation Drug-Eluting Stent and Drug Balloon Angioplasty |
Okgeun Kim, Il Rhee, Jigeon Jang, WonIl Song, Jonghyun Lee, Minsung Kim |
Division of Cardiology, Department of Internal Medicine, Good Samsun Hospital, Busan, Korea |
1세대 약물 용출 스텐트 시술 후 발생한 스텐트 협착과 약물 풍선 혈관성형술 |
김옥근, 이일, 장지건, 송원일, 이종현, 김민성 |
좋은삼선병원 순환기내과 |
Correspondence:
Il Rhee, Tel: +82-51-322-0900, Fax: +82-51-323-3308, Email: cormed21@gmail.com |
Received: 19 August 2014 • Revised: 8 October 2014 • Accepted: 1 December 2014 |
|
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Abstract |
In patients with coronary artery disease, coronary stenting with a drug-eluting stent (DES) is associated with lower rates of in-stent restenosis and re-surgery for the target lesion compared with a bare metal stent, while late stent thrombosis has emerged as a life-threatening complication in patients treated with a first-generation DES. As no treatment has been established for potentially fatal late stent thrombosis associated with a first-generation DES, we perform drug balloon angioplasty for patients with stent thrombosis and in-stent restenosis associated with DES. Here, we reported the cases with normal coronary artery flow after a 2-year follow-up. |
Key Words:
Stent thrombosis; In-stent restenosis; Drug balloon angioplasty |
주제어:
스텐트 혈전증; 스텐트 내 재협착; 약물 풍선 혈관성형술 |